| Aug 9 |
Earnings Update: AbCellera Biologics Inc. (NASDAQ:ABCL) Just Reported And Analysts Are Trimming Their Forecasts
|
| Aug 5 |
AbCellera Biologics Q2 2024 Earnings Preview
|
| Aug 1 |
AbCellera and Lilly broadens antibody discovery partnership
|
| Jul 31 |
AbCellera and Lilly Expand Collaboration to Develop Antibody Medicines
|
| Jul 21 |
Billionaires Are Buying These 2 Beaten-Down Stocks. Are They Smart Buys for Your Portfolio?
|
| Jul 9 |
AbCellera Biologics (ABCL) Upgraded to Buy: Here's What You Should Know
|
| Jun 25 |
AbCellera to Report Second Quarter 2024 Financial Results on August 6, 2024
|
| Jun 6 |
We're Not Very Worried About AbCellera Biologics' (NASDAQ:ABCL) Cash Burn Rate
|
| May 28 |
AbCellera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024
|
